症状性颅内动脉粥样硬化性狭窄血管支架置入术后再狭窄的研究进展

Abstract
Figure/Table
References (31)
Related Citation (15)

Download: PDF (0 KB) HTML (42 KB)
Export: BibTeX | EndNote (RIS)

Abstract Ischemic stroke refers to the disturbance of blood flow in the blood supply artery of the local brain tissue caused by various reasons, which leads to the ischemic hypoxic degeneration and necrosis of the brain tissue. At the same time, the corresponding clinical neurological function loss occurs. It is one of the diseases with the highest disability rate in the human disease spectrum, which brings heavy burden to the patients′ family and the whole society. In the TOAST etiology classification of ischemic stroke, the proportion of intracranial artery stenosis caused by large intracranial atherosclerosis is about 17.3%, in which intravascular interventional therapy has been widely used. With the development of stent therapy, long-term complications such as in-stent restenosis (ISR) have attracted more and more attention. On the basis of the research at home and abroad in recent years, this paper reviews the incidence, mechanism, risk factors, assessment methods and Countermeasures of ISR, so as to provide evidence for the safety and effectiveness of different intracranial endovascular stent therapy, and to provide help in the selection of treatment methods of intracranial atherosclerotic ischemic stroke and the perioperative and long-term management of patients.

Key words： In-stent restenosis Atherosclerotic stenosis Ischemic stroke Stent implantation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	PENG Wei
	LUO Hai-yan

Cite this article:

PENG Wei,LUO Hai-yan. Research progress of in-stent restenosis after stent implantation in symptomatic atherosclerotic intracranial stenosis[J]. 中国当代医药, 2020, 27(7): 21-24.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I7/21

[1]	Zhao D，Liu J，Wang W，et al.Epidemiological transition of stroke in China：twenty-one-year observational study from the Sino-MONICA-Beijing Project[J].Stroke，2008，39（6）：1668-1674.
[6]	Weisberg LA.Clinical characteristics of transient is chemic attacks in black patients[J].Neurology，1991，41（9）：1410.
[8]	Wong LKS.Global burden of intracranial atherosclerosis[J].Int J Stroke，2006，1（3）：158-159.
[10]	支晓东，石向群.颅内动脉狭窄支架置入后对脑动脉及其供血脑组织影响的研究进展[J].中国脑血管病杂志，2014，11（7）：385-388.
[2]	Holmstedt CA，Turan TN，Chimowitz MI.Atherosclerotic intracranial arterial stenosis：risk factors，diagnosis，and treatment[J].Lancet Neurol，2013，12（11）：1106-1114.
[3]	Gorelick PB，Wong KS，Bae HJ，et al.Large artery intracranial occlusive disease：a large worldwide burden but a relatively neglected frontier[J].Stroke，2008，39（8）：2396-2399.
[4]	Sacco RL，Kargman DE，Gu Q，et al.Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction：the Northern Manhattan Stroke Study[J].Stroke，1995，26（1）：14-20.
[5]	Qureshi AI，Safdar K，Patel M，et al.Stroke in young black patients：risk factors，subtypes，and prognosis[J].Stroke，1995，26（11）：1995-1998.
[7]	Wityk RJ，Lehman D，Klag M，et al.Race and sex differences in the distribution of cerebral atherosclerosis[J].Stroke，1996，27（11）：1974-1980.
[9]	Zhou M，Wang H，Zhu J，et al.Cause-specific mortality for 240 causes in China during 1990～2013：a systematic subnational analysis for the Global Burden of Disease Study 2013[J].The Lancet，2016，387（10015）：251-272.
[11]	Morice MC，Colombo A，Meier B，et al.Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions：the REALITY trial：a randomized controlled trial [J].Jama，2006，295（8）：895-904.
[12]	Mehran R，Dangas G，Abizaid AS，et al.Angiographic patterns of in-stent restenosis：classification and implications for long-term outcome[J].Circulation，1999，100（18）：1872-1878.
[13]	Koh W，Kallenberg K，Karch A，et al.Transcranial doppler sonography is not a valid diagnostic tool for detection of basilar artery stenosis or in-stent restenosis：a retrospective diagnostic study[J].BMC Neurol，2017，17（1）：89.
[14]	Elwertowski M，Ma1ek G.Standards of the Polish Ultrasound Society-update.Examination of extracranial carotid and vertebral arteries[J].J Ultrason，2014，14（57）：179.
[15]	Madycki G，Gabriel M，Hawro P，et al.Duplex Doppler ultrasound examination of carotid and vertebral arteries：guidelines of the Polish Society for Vascular Surgery[J].Kardiol Pol，2014，72（3）：288-309.
[16]	AbuRahma AF，AbuRahma ZT，Scott G，et al.The incidence of carotid in-stent stenosis is underestimated ≥50% or≥80% and its clinical implications[J].J Vasc Surg，2019，69（6）：1807-1814.
[17]	Moon K，Alb uquerque FC，Levitt MR，et al.The myth of restenosis after carotid angioplasty and stenting[J].J Neurointerv Surg，2016，8（10）：1006-1010.
[18]	Ronchey S，Praquin B，Orrico M，et al.Outcomes of 1000 carotid Wallstent implantations：single-center experience[J].J Endovasc Ther，2016，23（2）：267-274.
[19]	Chen W，Huang F，Li M，et al.Incidence and Predictors of the In-stent restenosis after vertebral artery ostium stenting[J].J Stroke Cerebrovasc Dis，2018，27（11）：3030-3035.
[20]	Zheng D，Mingyue Z，Wei S，et al.The incidence and risk factors of in -stent restenosis for vertebrobasilar artery stenting[J].World Neurosurg，2018，110：e937-e941.
[21]	Waksman R，Iantorno M.Refractory in-stent restenosis：improving outcomes by standardizing our approach[J].Curr Cardiol Rep，2018，20（12）：140.
[22]	Yamashita K，Kokuzawa J，Kuroda T，et al.In-stent hypodense area at two weeks following carotid artery stenting predicts neointimal hyperplasia after two years[J].Neuroradiol J，2018，31（3）：280-287.
[23]	Tsuji Y，Koide M，Katsura K，et al.In-stent restenosis with“Inflammatory” neointima following everolimus -eluting stent implantation[J].Int Heart J，2018，59（5）：1142-1145.
[24]	Kayssi A，Al-Jundi W，Papia G，et al.Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries：protocols [Z]//Cochrane Database of Systematic Reviews.John Wiley & Sons，Ltd，2017.
[25]	Ye G，Yin X，Yang X，et al.Efficacy and safety of drug-eluting stent for the intracranial atherosclerotic disease：a systematic review and meta-analysis[J].J Clin Neurosci，2019，59：112-118.
[26]	Clark DJ，Lessio S，O′Donoghue M，et al.Mechanisms and predictors of carotid artery stent restenosis：a serial intravascular ultrasound study[J].J Am Coll Cardiol，2006，47（12）：2390-2396.
[27]	Shi R，Zhang R，Yang F，et al.Tissue Kallikrein prevents restenosis after stenting of severe atherosclerotic stenosis of the middle cerebral artery：a randomized controlled trial[J].Medicine，2016，95（6）：e2809.
[28]	Yang WJ，Fisher M，Zheng L，et all.Histological characteristics of intracranial atherosclerosis in a Chinese population：a postmortem study[J].Front Neurol，2017，8：488.
[29]	Thiel WH，Esposito CL，Dickey DD，et al.Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation[J].Mol Ther，2016，24（4）：779-787.
[30]	吴中华，仇汉诚，胡苏姗，等.症状性颅内支架内再狭窄的介入治疗[J].中华医学杂志，2018，98（37）：3017-3020.
[31]	Stilo F，Sirignano P，Montelione N，et al.Bypass for symptomatic in-stent carotid restenosis[J].Int J Cardiol，2017，249：392-395.